🔗 Share this article

A shadow market for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting substances of unknown origin.

Some experts said the demand for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or prison.

Platform Reaction and Material Elimination

Based on TikTok, the service has taken down problematic content and prohibited related keywords and query recommendations. The company stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also discovered groups with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays channels with numerous of users, filled with images of weight loss, glowing testimonials and detailed instructions for preparing or injecting at residence.

After moments of joining one community, a vendor shared contact information, where most purchases occur. The seller provided an guidebook and promised delivery within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.

Item Details and Costs

Within these groups, messages display dark colored parcels with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for Telegram stated it actively monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they cannot confirm. Even if the research behind this drug is sound, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has previously encountered patients injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational product not yet authorized … may expose users to potentially significant health risks”.